35 /100
MEDIUM RISK
Score updated Jul 14, 2026

LION — Lionsgate Studios Corp. Dilution Risk Tracker

Track LION dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LION — Get alerts when the score changes →

As of July 14, 2026, Lionsgate Studios Corp. (LION) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Lionsgate Studios Corp. has a market capitalization of $4.17B, 290.63M shares outstanding, 278 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LION.
🔔 Track LION — Get forecast alerts →

💹 Market Data

Market Cap$4.17B
Shares Outstanding290.63M
FloatN/A
Cash$341.50M
Debt$1.94B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.2% shares (2026Q1 vs prior)
278 institutional holders · 291.45M shares
#1 MHR FUND MANAGEMENT LLC 37.65M shares
#2 Liberty 77 Capital L.P. 37.55M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 20.34M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.50M
Days to Cover2.9
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

8-K 8K EVENT Apr 15, 2026
4 INSIDER TRANSACTION Apr 15, 2026
424B3 ATM Apr 15, 2026
4 INSIDER TRANSACTION Apr 10, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LION Shareholders

Lionsgate Studios Corp. (LION) has a DilutionScore of 35/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for LION shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LION in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for LION alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LION Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LION — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LION
📊 LION FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LION Signal Convergence & Dark Pool Activity — StonkWhisper 📄 LION Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.